Merck & Co. Case

Merck & Co., Inc (A) (The summary is based on the article in Vol. I and does not include the extra readings given by the professor) This bailiwick is a classic example of enterprises trying to balance their short letter of increasing profits and expected social responsibilities. This dilemma is get along accentuated when the company happens to be a pharma company whose decisions straightway affect peoples lives. The Dilemma: A thinkable drug for River Blindness, a disease which affects almost 85 jillion people in the third world countries, has been discovered as a derivative during Mercks explore on medicines for zoology health treatment. But the drug needs to be time-tested extensively and researched further before it can be employ in humans. This would require millions in investments but little financial returns, as most of the change people cannot afford the drug. Merck washed-out a lot of money on research and believed that its incoming success depended on inventing new drugs. The odds of developing a successful drug are rather low and fee-tail high investments. On an average it took 12 years and $cc million to bring a new drug to market.

So allocation of funds for this research would mean eating into some other drugs budget. Besides there were no US or international program to create incentives for companies to develop drugs for diseases that affected the poor in the third world countries. A viable hope for Merck was that some international organization like WHO index partially fund the program. Mercks researchers were the best paid in the industry and they thought of their work as a interest to alleviate human disease and suffering world-wide. Thus, refusal to fund the research might affect the morale of the team. This is the single biggest concern of Dr. Vagelos, the sharpen of Merck Research labs, while taking a call on the matter. If you want to get a full essay, order it on our website: Orderessay

If you want to get a full essay, wisit our page: write my essay .